These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 31819291)

  • 1. Provider and household costs of
    Devine A; Pasaribu AP; Teferi T; Pham HT; Awab GR; Contantia F; Nguyen TN; Ngo VT; Tran TH; Hailu A; Gilchrist K; Green JA; Koh GC; Thriemer K; Taylor WR; Day NP; Price RN; Lubell Y
    Bull World Health Organ; 2019 Dec; 97(12):828-836. PubMed ID: 31819291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Global economic costs due to vivax malaria and the potential impact of its radical cure: A modelling study.
    Devine A; Battle KE; Meagher N; Howes RE; Dini S; Gething PW; Simpson JA; Price RN; Lubell Y
    PLoS Med; 2021 Jun; 18(6):e1003614. PubMed ID: 34061843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment-seeking behaviour and associated costs for malaria in Papua, Indonesia.
    Karyana M; Devine A; Kenangalem E; Burdarm L; Poespoprodjo JR; Vemuri R; Anstey NM; Tjitra E; Price RN; Yeung S
    Malar J; 2016 Nov; 15(1):536. PubMed ID: 27821127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Costs Associated with Malaria in Pregnancy in the Brazilian Amazon, a Low Endemic Area Where Plasmodium vivax Predominates.
    Bôtto-Menezes C; Bardají A; Dos Santos Campos G; Fernandes S; Hanson K; Martínez-Espinosa FE; Menéndez C; Sicuri E
    PLoS Negl Trop Dis; 2016 Mar; 10(3):e0004494. PubMed ID: 27031515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness of malaria diagnosis using rapid diagnostic tests compared to microscopy or clinical symptoms alone in Afghanistan.
    Hansen KS; Grieve E; Mikhail A; Mayan I; Mohammed N; Anwar M; Baktash SH; Drake TL; Whitty CJ; Rowland MW; Leslie TJ
    Malar J; 2015 May; 14():217. PubMed ID: 26016871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Using G6PD tests to enable the safe treatment of Plasmodium vivax infections with primaquine on the Thailand-Myanmar border: A cost-effectiveness analysis.
    Devine A; Parmiter M; Chu CS; Bancone G; Nosten F; Price RN; Lubell Y; Yeung S
    PLoS Negl Trop Dis; 2017 May; 11(5):e0005602. PubMed ID: 28542194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-Effectiveness Analysis of Sex-Stratified
    Devine A; Howes RE; Price DJ; Moore KA; Ley B; Simpson JA; Dittrich S; Price RN
    Am J Trop Med Hyg; 2020 Jul; 103(1):394-403. PubMed ID: 32372747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improving the radical cure of vivax malaria (IMPROV): a study protocol for a multicentre randomised, placebo-controlled comparison of short and long course primaquine regimens.
    IMPROV Study Group
    BMC Infect Dis; 2015 Dec; 15():558. PubMed ID: 26643116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Costs and Cost-Effectiveness of Plasmodium vivax Control.
    White MT; Yeung S; Patouillard E; Cibulskis R
    Am J Trop Med Hyg; 2016 Dec; 95(6 Suppl):52-61. PubMed ID: 28025283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The economic burden of zoonotic
    Abraham P; McMullin C; William T; Rajahram GS; Jelip J; Teo R; Drakeley C; Manah AM; Anstey NM; Grigg MJ; Devine A
    medRxiv; 2024 May; ():. PubMed ID: 38746350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tafenoquine plus chloroquine for the treatment and relapse prevention of Plasmodium vivax malaria (DETECTIVE): a multicentre, double-blind, randomised, phase 2b dose-selection study.
    Llanos-Cuentas A; Lacerda MV; Rueangweerayut R; Krudsood S; Gupta SK; Kochar SK; Arthur P; Chuenchom N; Möhrle JJ; Duparc S; Ugwuegbulam C; Kleim JP; Carter N; Green JA; Kellam L
    Lancet; 2014 Mar; 383(9922):1049-58. PubMed ID: 24360369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Economic costs analysis of uncomplicated malaria case management in the Peruvian Amazon.
    Moreno-Gutierrez D; Rosas-Aguirre A; Llanos-Cuentas A; Bilcke J; Barboza JL; Hayette MP; Contreras-Mancilla J; Aguirre K; Gamboa D; Rodriguez H; Speybroeck N; Beutels P
    Malar J; 2020 Apr; 19(1):161. PubMed ID: 32316981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unsupervised primaquine for the treatment of Plasmodium vivax malaria relapses in southern Papua: A hospital-based cohort study.
    Douglas NM; Poespoprodjo JR; Patriani D; Malloy MJ; Kenangalem E; Sugiarto P; Simpson JA; Soenarto Y; Anstey NM; Price RN
    PLoS Med; 2017 Aug; 14(8):e1002379. PubMed ID: 28850568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-utility of tafenoquine vs. primaquine for the radical cure (prevention of relapse) of
    Kostić M; Milosavljević MN; Stefanović S; Ranković G; Janković SM
    J Chemother; 2020 Feb; 32(1):21-29. PubMed ID: 31524099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short-course primaquine for the radical cure of Plasmodium vivax malaria: a multicentre, randomised, placebo-controlled non-inferiority trial.
    Taylor WRJ; Thriemer K; von Seidlein L; Yuentrakul P; Assawariyathipat T; Assefa A; Auburn S; Chand K; Chau NH; Cheah PY; Dong LT; Dhorda M; Degaga TS; Devine A; Ekawati LL; Fahmi F; Hailu A; Hasanzai MA; Hien TT; Khu H; Ley B; Lubell Y; Marfurt J; Mohammad H; Moore KA; Naddim MN; Pasaribu AP; Pasaribu S; Promnarate C; Rahim AG; Sirithiranont P; Solomon H; Sudoyo H; Sutanto I; Thanh NV; Tuyet-Trinh NT; Waithira N; Woyessa A; Yamin FY; Dondorp A; Simpson JA; Baird JK; White NJ; Day NP; Price RN
    Lancet; 2019 Sep; 394(10202):929-938. PubMed ID: 31327563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Improving Community-Based Access to Malaria Diagnosis and Treatment on Household Costs.
    Castellani J; Nsungwa-Sabiiti J; Mihaylova B; Ajayi IO; Siribié M; Afonne C; Balyeku A; Sermé L; Sanou AK; Sombié BS; Tiono AB; Sirima SB; Kabarungi V; Falade CO; Kyaligonza J; Evers SM; Paulus AT; Petzold M; Singlovic J; Gomes M
    Clin Infect Dis; 2016 Dec; 63(suppl 5):S256-S263. PubMed ID: 27941102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tafenoquine exposure assessment, safety, and relapse prevention efficacy in children with Plasmodium vivax malaria: open-label, single-arm, non-comparative, multicentre, pharmacokinetic bridging, phase 2 trial.
    Vélez ID; Hien TT; Green JA; Martin A; Sharma H; Rousell VM; Breton JJ; Ernest TB; Rolfe K; Taylor M; Mohamed K; Jones SW; Chau NH; Hoa NT; Duparc S; Tan LK; Goyal N
    Lancet Child Adolesc Health; 2022 Feb; 6(2):86-95. PubMed ID: 34871570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single-Dose Tafenoquine to Prevent Relapse of Plasmodium vivax Malaria.
    Lacerda MVG; Llanos-Cuentas A; Krudsood S; Lon C; Saunders DL; Mohammed R; Yilma D; Batista Pereira D; Espino FEJ; Mia RZ; Chuquiyauri R; Val F; Casapía M; Monteiro WM; Brito MAM; Costa MRF; Buathong N; Noedl H; Diro E; Getie S; Wubie KM; Abdissa A; Zeynudin A; Abebe C; Tada MS; Brand F; Beck HP; Angus B; Duparc S; Kleim JP; Kellam LM; Rousell VM; Jones SW; Hardaker E; Mohamed K; Clover DD; Fletcher K; Breton JJ; Ugwuegbulam CO; Green JA; Koh GCKW
    N Engl J Med; 2019 Jan; 380(3):215-228. PubMed ID: 30650322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-Benefit Analysis of Tafenoquine for Radical Cure of
    Suh J; Kim JH; Kim JD; Kim C; Choi JY; Lee J; Yeom JS
    J Korean Med Sci; 2022 Jul; 37(27):e212. PubMed ID: 35818703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.